SCHEMBL1609762

SCHEMBL1609762

COC(=O)c1nc(C2CC2)nc(NCc2ccc(OC)cc2OC)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP1A2 P05177 9/20 0.43
CYP3A4 P08684 9/20 0.43
CYP2C19 P33261 9/20 0.43
CYP2D6 P10635 8/20 0.43
ALDH1A1 P00352 7/20 0.43
TSHR P16473 7/20 0.43
CYP2C9 P11712 6/20 0.43
HSD17B10 Q99714 5/20 0.43
HIF1A Q16665 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4C Q9H3R0 1/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
ALOX15 P16050 2/20 0.41
KDM4E B2RXH2 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1611399 0.92 KDM4C (0.47) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL13769165 0.90 PDE10A (0.40) MAPTCYP3A4CYP2D6ALDH1A1HPGD
SCHEMBL12712820 0.90 PDE10A (0.40) MAPTCYP3A4CYP2D6KDM4CHPGD
SCHEMBL1610305 0.87 PDE10A (0.44) MAPTALDH1A1HSD17B10HIF1AHPGD
SCHEMBL2683023 0.86 KDM4C (0.49) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL1610899 0.85 PDE10A (0.48) MAPTALDH1A1RAB9A
SCHEMBL12737605 0.83 APLNR (0.44) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL1609110 0.83 HPGD (0.50) ALDH1A1HSD17B10HPGDSMN1; SMN2NPSR1
SCHEMBL13769408 0.82 PDE10A (0.44) CYP3A4CYP2D6ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL13769420 0.82 MTNR1A (0.41) MAPTALDH1A1TDP1KDM4CHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 MAPT 2800/4885MEN1 3860/4885KMT2A 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.